Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
R. Tkacova (Kosice, Slovakia). Can CPAP reduce adverse cardiovascular and metabolic effects of OSAS?. Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)

Member's Comments

No comment yet.

Related content which might interest you: CPAP and measures of cardiovascular risks in patients with OSAS Source: Eur Respir J 2009; 33: 1520 Year: 2009 Metabolic effects of OSAS and cardiovascular risk Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS) Year: 2007 Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment Source: Eur Respir J 2012; 39: 906-912 Year: 2012 Co-morbidities and cardiovascular medications are the best predictors of mortality in patients with obesity-associated hypoventilation treated with long-term non-invasive ventilation Source: Annual Congress 2012 - Current trends in home mechanical ventilation Year: 2012 Weight and metabolic effects of CPAP in OSA patients with obesity Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010 CPAP in the elderly with non-severe obstructive sleep apnea: effect on cardiovascular events and somnolence. Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment Year: 2017 Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008 CPAP therapy in OSA patients: The effects on healthcare use and medical costs related to cardio- and cerebrovascular diseases Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Targeting the detrimental effects of sleep disturbances in OSA: CPAP and what else? Source: Research seminar - Targeting the detrimental effects of sleep disturbances and disorders – towards personalized treatment in respiratory diseases Year: 2019 CPAP vs APAP effects on metabolic and cardiac function in patients with OSAS Source: Eur Respir J 2005; 26: Suppl. 49, 722s Year: 2005 Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Combination between sleep apnoea and COPD: a synergistic risk for cardiovascular diseases? Source: Sleep and Breathing Conference 2017 Year: 2017 Sleep apnoea and systemic hypertension Source: Eur Respir Mon 2010; 50: 150-173 Year: 2010 Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 320s Year: 2007 OSAS and the incidence of cardiovascular disorders Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 CPAP can decrease fatal and non-fatal cardiovascular events in OSAH Source: ISSN=ISSN 1810-6838, ISBN=, page=266 Year: 2006 Cardiovascular regulation effects of CPAP therapy in obstructive sleep apnea patients with and without hypertension during daytime Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II Year: 2012 The effect of sleep-disordered breathing (SDB) on adverse consequences associated with opioid use: A population study Source: Virtual Congress 2020 – Determinants of chronic respiratory diseases Year: 2020